Literature DB >> 25613512

MicroRNA landscape in Alzheimer's disease.

Carlo Cogoni, Francesca Ruberti, Christian Barbato1.   

Abstract

Individual microRNAs and/or microRNA signatures were associated with Alzheimer's disease (AD). We report here the recent advances brought to the identification of microRNA changes in AD brain and their biological function in the molecular pathways associated with the disease. This field represents a fertile route to understand the pathogenic mechanisms underlying Alzheimer's disease. In addition we review recent studies aimed to discover promising biomarkers for AD diagnosis by microRNA expression profiles of biofluids from AD patients.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25613512     DOI： 10.2174/1871527314666150116123305

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN： 1871-5273            Impact factor:   4.388


  9 in total

Review 1.  Role of viruses, prions and miRNA in neurodegenerative disorders and dementia.

Authors:  Sayed Sartaj Sohrab; Mohd Suhail; Ashraf Ali; Mohammad Amjad Kamal; Azamal Husen; Fahim Ahmad; Esam Ibraheem Azhar; Nigel H Greig
Journal:  Virusdisease       Date:  2018-09-29

Review 2.  MicroRNA (miRNA)-Mediated Pathogenetic Signaling in Alzheimer's Disease (AD).

Authors:  James M Hill; Walter J Lukiw
Journal:  Neurochem Res       Date:  2015-10-06       Impact factor: 3.996

3.  microRNA-132/212 deficiency enhances Aβ production and senile plaque deposition in Alzheimer's disease triple transgenic mice.

Authors:  Julia Hernandez-Rapp; Sara Rainone; Claudia Goupil; Véronique Dorval; Pascal Y Smith; Martine Saint-Pierre; Maxime Vallée; Emmanuel Planel; Arnaud Droit; Frédéric Calon; Francesca Cicchetti; Sébastien S Hébert
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

4.  MicroRNA (miRNA) Signaling in the Human CNS in Sporadic Alzheimer's Disease (AD)-Novel and Unique Pathological Features.

Authors:  Yuhai Zhao; Aileen I Pogue; Walter J Lukiw
Journal:  Int J Mol Sci       Date:  2015-12-17       Impact factor: 5.923

5.  Modulation of miR-146a/complement factor H-mediated inflammatory responses in a rat model of temporal lobe epilepsy.

Authors:  Fang He; Bei Liu; Qiang Meng; Yang Sun; Weiwen Wang; Chao Wang
Journal:  Biosci Rep       Date:  2016-12-23       Impact factor: 3.840

6.  MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints.

Authors:  Andrea Vergallo; Simone Lista; Yuhai Zhao; Pablo Lemercier; Stefan J Teipel; Marie-Claude Potier; Marie-Odile Habert; Bruno Dubois; Walter J Lukiw; Harald Hampel
Journal:  Transl Psychiatry       Date:  2021-01-27       Impact factor: 6.222

7.  The Neuroprotective Effect of miR-136 on Pilocarpine-Induced Temporal Lobe Epilepsy Rats by Inhibiting Wnt/β-Catenin Signaling Pathway.

Authors:  Hongxia Cui; Weihao Zhang
Journal:  Comput Math Methods Med       Date:  2022-02-26       Impact factor: 2.238

8.  Aberrant miR-339-5p/neuronatin signaling causes prodromal neuronal calcium dyshomeostasis in mutant presenilin mice.

Authors:  Hao-Yu Zou; Lin Guo; Bei Zhang; Si Chen; Xin-Rong Wu; Xian-Dong Liu; Xin-Yu Xu; Bin-Yin Li; Shengdi Chen; Nan-Jie Xu; Suya Sun
Journal:  J Clin Invest       Date:  2022-04-15       Impact factor: 19.456

9.  MicroRNA-Mediated Silencing Pathways in the Nervous System and Neurological Diseases.

Authors:  Christian Barbato
Journal:  Cells       Date:  2022-08-02       Impact factor: 7.666
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.